ANDA 85381, held by Medpointe Pharm Hlc. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85381 (Buticaps), held by Medpointe Pharm Hlc, was first approved by FDA on Apr 11, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 1978 | Original application | Approved | None posted |
| Buticaps15MG · capsule;oral | Butabarbital Sodium | Discontinued |
| Buticaps30MG · capsule;oral | Butabarbital Sodium | Discontinued |
| Buticaps50MG · capsule;oral | Butabarbital Sodium | Discontinued |
| Buticaps100MG · capsule;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters